Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Phospholipid metabolism in zymosan stimulated human monocytes: modulation by cyclic AMP (cAMP)

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:7170686

Oxygenated products of arachidonic acid (AA) are critical components in the development of the inflammatory response. Monocytes exposed to inflammatory stimuli are capable of converting free AA into these bioactive molecules. However, the limiting step in the formation of these compounds is thought to be the mechanism responsible for the release of esterified AA from phospholipids. When (/sup 3/H) AA labeled monocytes were challenged with opsonized zymosan, 28 +/- 2% of the incorporated counts were released compared to 8 +/- 1% for the control. Upon pretreatment with isobutyl methyl xanthine (IBMX) or dibutyrl cyclic AMP (d-cAMP) zymosan stimulated AA release was markedly reduced. The IC/sub 50/'s were 4 x 10/sup -4/M and 7 x 10/sup -4/M respectively. Analysis of (/sup 3/H) AA incorporation into cellular phospholipids showed that phosphatidylcholine (PC) and phosphatidylinositol (PI) were the primary pools labeled. Loss of label from both of these pools was evident after exposure to zymosan, however, pretreatment of cells with IBMX or d-cAMP inhibited release of (/sup 3/H)AA from the PC pool but not from the PI pool. The results show that human monocytes challenged with opsonized zymosan release arachidonic acid via cAMP-dependent and independent pathways. Furthermore, they suggest that a phospholipase activity (possibly A/sub 2/) against PC is modulated by cAMP.

Research Organization:
Smith Kline and French Labs., Philadelphia, PA
OSTI ID:
7170686
Report Number(s):
CONF-8606151-
Journal Information:
Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States), Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Vol. 45:6; ISSN FEPRA
Country of Publication:
United States
Language:
English